David W. Grainger Joins Drug Delivery Journal as Co-Editor-in-Chief

Important New Appointment Also Signals a Call For New Manuscripts

NEW YORK, January 22 /PRNewswire/ -- David W. Grainger, Ph.D., has joined
the Drug Delivery journal as co-Editor-in-Chief. Drug Delivery, published by
Informa Healthcare, a leading content provider of pharmaceutical science
information for the academic and industrial communities with peer reviewed
coverage of basic research, development, and application principles at
molecular, cellular, and higher levels.
Dr. Grainger, currently professor and chair of the Department of
Pharmaceutics and Pharmaceutical Chemistry in the College of Pharmacy at the
University of Utah, is an international respected and award-winning professor
and scholar in the drug delivery and biomedical device field. His new
appointment seeks to guide the journal's overall direction within the drug
delivery community as this field evolves and integrates with emerging science
and technology. It also signals an invitation for new high-quality
manuscripts now being accepted for consideration for publication in Drug
Delivery.
"Dr. Grainger's new position as co-Editor-in-Chief of Drug Delivery
signifies an exciting new direction for us," says Carolyn Honour, vice
president and publishing director, Informa Healthcare, Pharmaceutical
Science. "Dr. Grainger's expertise offers a fresh perspective on current
research and development in this area and should establish a new era of
leadership for a journal that carries a tradition of delivering quality
articles to the scientific community."
Drug Delivery publishes original research, critical reviews, book
reviews, and industry announcements such as patent updates, literature
alerts, and news of important events.
"I'm really excited and challenged about my new role at Drug Delivery,"
declares Dr. Grainger. "I'm looking forward to attracting, acquiring-and
publishing-the highest quality and most impacting research articles to help
advance and disseminate the work being done in this field."
Dr. Grainger, a past member of the scientific advisory board and annual
symposium chair for the Controlled Release Society, holds many advisory panel
positions within the industry. Among the many honors he has received is the
PhRMA Foundation's "Excellence in Pharmaceutics" Award (2005) and the Society
for Biomaterials' Clemson Award for Basic Research in Biomaterials (2007). He
earned his Ph.D. in Pharmaceutical Chemistry from University of Utah.
Drug Delivery is published eight times per year. To submit scientific
articles within this field or to view the instructions for authors, visit
http://www.informaworld.com/udrd.
About Informa Healthcare
Informa Healthcare provides authoritative research and analysis,
up-to-the-minute news, comment and debate for all sectors of the Healthcare
and Life Sciences community to better serve the commercial and academic needs
within the scientific and healthcare communities. Informa Healthcare is a
division of Informa plc (London: INF). Informa has more than 150 offices in
40 countries and employs 7,500 staff around the world. Informa Healthcare is
headquartered in Manhattan, New York. For more information, visit
http://www.informahealthcare.com.
Andrew White
Informa Healthcare
+1-978-618-8143
andrew.white@informausa.com

SOURCE Informa Healthcare

Andrew White, Informa Healthcare, +1-978-618-8143,
andrew.white@informausa.com